Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Maggi

Showing results (281-290 of 298) with videos related to

Pageof 30
Sort By:
Vaccines|July 27, 2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS StudyAlessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
Vaccines|November 25, 2023
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 RatioAlessandra Vergori, Alessandro Tavelli, Giulia Matusali, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 16, 2019
Prevalence and Loads of Torquetenovirus in the European MARK-AGE Study PopulationRobertina Giacconi, Fabrizio Maggi, Lisa Macera, et al.
International Immunopharmacology|September 25, 2025
Genetic variability of respiratory syncytial virus and its impact on monoclonal antibody binding sites: a national cross-sectional study during the 2023-2024 seasonAntonio Piralla, Greta Romano, Carla Acciarri, et al.
Vaccines|November 25, 2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 VaccineAndrea Picchianti-Diamanti, Assunta Navarra, Alessandra Aiello, et al.
Eclinicalmedicine|January 31, 2024
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort studyValentina Mazzotta, Alessandro Cozzi Lepri, Giulia Matusali, et al.
Vaccines|January 24, 2025
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous RouteValentina Mazzotta, Pierluca Piselli, Alessandro Cozzi Lepri, et al.
Journal of Medical Virology|May 6, 2025
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target TrialsValentina Mazzotta, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.
Journal of Medical Virology|May 29, 2023
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomesAnnalisa Mondi, Ilaria Mastrorosa, Pierluca Piselli, et al.
The Journal of Infectious Diseases|July 16, 2025
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022-2024, With a Focus on Adults Over 50 Years of AgeAlessandro Mancon, Laura Pellegrinelli, Greta Romano, et al.
Pageof 30

Showing results (281-290 of 298) with videos related to

Sort By:
Pageof 30
Vaccines|July 27, 2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS StudyAlessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
Vaccines|November 25, 2023
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 RatioAlessandra Vergori, Alessandro Tavelli, Giulia Matusali, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 16, 2019
Prevalence and Loads of Torquetenovirus in the European MARK-AGE Study PopulationRobertina Giacconi, Fabrizio Maggi, Lisa Macera, et al.
International Immunopharmacology|September 25, 2025
Genetic variability of respiratory syncytial virus and its impact on monoclonal antibody binding sites: a national cross-sectional study during the 2023-2024 seasonAntonio Piralla, Greta Romano, Carla Acciarri, et al.
Vaccines|November 25, 2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 VaccineAndrea Picchianti-Diamanti, Assunta Navarra, Alessandra Aiello, et al.
Eclinicalmedicine|January 31, 2024
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort studyValentina Mazzotta, Alessandro Cozzi Lepri, Giulia Matusali, et al.
Vaccines|January 24, 2025
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous RouteValentina Mazzotta, Pierluca Piselli, Alessandro Cozzi Lepri, et al.
Journal of Medical Virology|May 6, 2025
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target TrialsValentina Mazzotta, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.
Journal of Medical Virology|May 29, 2023
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomesAnnalisa Mondi, Ilaria Mastrorosa, Pierluca Piselli, et al.
The Journal of Infectious Diseases|July 16, 2025
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022-2024, With a Focus on Adults Over 50 Years of AgeAlessandro Mancon, Laura Pellegrinelli, Greta Romano, et al.
Pageof 30